Technical Analysis for PRCT - PROCEPT BioRobotics Corporation
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Slingshot Bullish | Bullish Swing Setup | -0.86% | |
| Earnings Movers | Other | -0.86% | |
| New 52 Week High | Strength | -1.24% | |
| 20 DMA Support | Bullish | -3.57% | |
| 50 DMA Support | Bullish | -3.57% | |
| New 52 Week Closing High | Bullish | -3.57% |
| Alert | Time |
|---|---|
| Possible NR7 | about 15 hours ago |
| Possible Inside Day | about 15 hours ago |
| 10 DMA Support | about 17 hours ago |
| Down 2 % | about 18 hours ago |
| 60 Minute Opening Range Breakdown | about 18 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/25/2024
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is based in Redwood City, California.
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Urology Benign Prostatic Hyperplasia Minimally Invasive Surgery Robot Assisted Surgery Bph Urologic Surgery
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Urology Benign Prostatic Hyperplasia Minimally Invasive Surgery Robot Assisted Surgery Bph Urologic Surgery
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 54.79 |
| 52 Week Low | 24.83 |
| Average Volume | 508,169 |
| 200-Day Moving Average | 39.73 |
| 50-Day Moving Average | 49.33 |
| 20-Day Moving Average | 50.37 |
| 10-Day Moving Average | 51.72 |
| Average True Range | 2.48 |
| RSI (14) | 54.95 |
| ADX | 13.04 |
| +DI | 23.53 |
| -DI | 19.14 |
| Chandelier Exit (Long, 3 ATRs) | 47.34 |
| Chandelier Exit (Short, 3 ATRs) | 53.01 |
| Upper Bollinger Bands | 55.18 |
| Lower Bollinger Band | 45.56 |
| Percent B (%b) | 0.65 |
| BandWidth | 19.08 |
| MACD Line | 1.01 |
| MACD Signal Line | 0.90 |
| MACD Histogram | 0.1084 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 54.38 | ||||
| Resistance 3 (R3) | 54.41 | 53.59 | 53.96 | ||
| Resistance 2 (R2) | 53.59 | 52.94 | 53.58 | 53.81 | |
| Resistance 1 (R1) | 52.71 | 52.54 | 52.30 | 52.68 | 53.67 |
| Pivot Point | 51.89 | 51.89 | 51.69 | 51.88 | 51.89 |
| Support 1 (S1) | 51.01 | 51.24 | 50.60 | 50.98 | 49.99 |
| Support 2 (S2) | 50.19 | 50.84 | 50.18 | 49.85 | |
| Support 3 (S3) | 49.31 | 50.19 | 49.71 | ||
| Support 4 (S4) | 49.28 |
